Related Experiment Video
Updated: Oct 27, 2025

10:02
Assessment of Spontaneous Alternation, Novel Object Recognition and Limb Clasping in Transgenic Mouse Models of Amyloid-β and Tau Neuropathology
Published on: May 28, 2017
27.4K
Protocols for assessing neurodegenerative phenotypes in Alzheimer's mouse models
Jongkyun Kang1, Hirotaka Watanabe2, Jie Shen1,3
1Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
STAR Protocols
|July 21, 2021
Summary
This study details a robust protocol for quantifying brain changes in Alzheimer's disease mouse models. This method ensures accurate neuropathological assessment and can be adapted for other neurological disorders.
Area of Science:
- Neuroscience
- Neuropathology
- Animal Models
Background:
- Quantitative assessment of neuropathological changes is critical for characterizing neurodegenerative disease animal models.
- Alzheimer's disease research relies heavily on accurate analysis of brain pathology in mouse models.
Purpose of the Study:
- To provide a detailed protocol for detecting and quantifying key neuropathological changes in Alzheimer's disease mouse models.
- To establish standardized methods for reproducible neuropathological analysis in preclinical research.
Main Methods:
- The protocol encompasses brain perfusion, dissection, paraffinization, and preparation of serial sections.
- It includes immunohistochemical analysis, stereological quantification, and genotype-blinded sample coding.
- Methods are designed for detailed and accurate assessment of brain tissue.
Main Results:
- The described protocol enables precise detection and quantification of neuropathological hallmarks.
- Standardized procedures ensure reliable and reproducible results in Alzheimer's mouse models.
- The methodology facilitates objective neuropathological characterization.
Conclusions:
- This protocol offers a comprehensive approach for analyzing neuropathological changes in Alzheimer's disease mouse models.
- The methods described are adaptable for studying other neurological disorders.
- Implementation of this protocol enhances the rigor of preclinical neurodegenerative disease research.

